
Zenocite 500mg Tablet
Marketer
Unimark Remedies Ltd
Salt Composition
Capecitabine (500mg)
Overview Zenocite 500mg Tablet
Oncasis 500mg tablets are indicated for the management of breast, colorectal, and rectal cancers. Additional uses may be determined by your physician. This medication is administered alone or in conjunction with other therapies as part of a chemotherapy regimen. Oncasis 500mg tablets should be ingested with food, within 30 minutes post-meal. Dosage and frequency will be prescribed by your doctor, tailored to your specific treatment needs and subject to change. Strictly adhere to your physician's instructions; incorrect usage or overdose can lead to severe adverse reactions. Therapeutic effects may not be apparent for several weeks or months; discontinue use only under medical guidance. Common side effects include emesis, asthenia, nausea, abdominal discomfort, and diarrhea. This medication can decrease blood cell counts (specifically white blood cells), increasing infection risk. Regular blood tests are necessary to monitor blood cell levels, along with cardiac, hepatic, and uric acid levels. Prior to commencing treatment, inform your physician of any pre-existing hepatic or renal conditions, or concurrent use of anti-infective medications. Interactions with numerous other drugs are possible; disclose all medications to your doctor. This medication is contraindicated during pregnancy and lactation. The use of reliable contraception by both partners is crucial to prevent conception during treatment.
Uses of Zenocite 500mg Tablet
Carcinoma of the breast and colorectal cancer
Major Benefits of Zenocite 500mg Tablet:
Consume this medication precisely as prescribed by your physician, adhering to both the dosage and treatment length. Ingest the 500mg Zenocite tablet whole; avoid chewing, crushing, or fracturing it. Administer this medication with a meal.
Common Side effects of Zenocite 500mg Tablet:
- Vomiting
- Weakness
- Nausea
- Abdominal pain
- Diarrhea
- Blisters on fingers/feet
How to use Zenocite 500mg Tablet:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the 500mg Zenocite tablet whole; avoid chewing, crushing, or breaking it. Administer this medicine with food.
How Zenocite 500mg Tablet works:
Zenocite 500mg tablets are an anti-cancer agent. Metabolic processes transform this drug into 5-fluorouracil, which inhibits the production of essential genetic components (RNA and DNA) within cancerous cells. This disruption of cellular function impedes cancer cell proliferation, ultimately leading to their demise.
SAFETY ADVICE
AlcoholCONSULT YOUR DOCTOR
Alcohol consumption alongside Zenocite 500mg tablets may pose unknown risks. Seek medical advice before combining them.
PregnancyCONSULT YOUR DOCTOR
Taking Zenocite 500mg tablets during pregnancy poses a confirmed risk to the fetus. Prescribing it is uncommon except in potentially fatal circumstances where the potential advantages outweigh the known hazards. Always seek medical advice.
Breast feedingUNSAFE
Breastfeeding mothers should avoid Zenocite 500mg tablets. Evidence indicates potential infant toxicity from this medication.
DrivingUNSAFE
Taking a Zenocite 500mg tablet could reduce attentiveness, impair vision, and cause drowsiness or dizziness. Driving should be avoided if these effects are experienced.
KidneyCAUTION
Patients with kidney impairment should exercise caution when using Zenocite 500mg tablets, as dose modification may be necessary. Severe kidney disease contraindicates the use of Zenocite 500mg tablets; physician consultation is advised.
LiverCAUTION
Patients with liver impairment should use Zenocite 500mg tablets cautiously; dosage modification may be necessary. Physician consultation is advised. Zenocite 500mg tablets are contraindicated in individuals with severe renal dysfunction.
What if you forget to take Zenocite 500mg Tablet :
NA
Facts to Know About Zenocite 500mg Tablet
| Label | Value |
|---|---|
| Chemical Classification | Modified Deoxycytidine |
| Developing Habits | No. |
| Treatment Category | Cancer Drugs |
| Actions | Metabolic inhibitors |
